Today's Healthcare Pulse
Allogene Therapeutics CEO David Chang to step down
Allogene Therapeutics announced that chief executive David Chang will leave his role. The news was reported by STAT+ and echoed in a follow‑up piece covering broader pharma updates.
Also developing:
By the numbers: Boston Scientific invests $1.5B for 34% stake in MiRus
Xenon’s Azetukalner Clears Phase III Hurdle in Focal Epilepsy, Eyes FDA Filing
Xenon Pharmaceuticals reported on 19 April at the American Academy of Neurology that its KV7 potassium‑channel opener azetukalner met primary endpoints in the Phase III X‑TOLE2 trial for focal onset seizures. The study enrolled 380 adults, with 374 completing safety and efficacy analyses, and showed statistically significant seizure reductions versus placebo. The data positions azetukalner as a possible first‑in‑class therapy pending regulatory review.
From Dorm to $275M: Early Ovarian Cancer Detection Breakthrough
This is my friend Surbhi Sarna. She came to Draper University in 2012. She had painful ovarian cysts as a teenager, but doctors didn’t have tools that could detect cancer without harming the ovaries. She studied molecular biology at UC Berkeley. Then came...
The $500,000 Drug and the Cost of Modern Medicine
A 70‑year‑old man with no cardiac symptoms was diagnosed with wild‑type transthyretin amyloid cardiomyopathy after a routine coronary calcium scan revealed a score over 600. The diagnosis triggered a cascade of advanced imaging and a biopsy, leading to approval of...
Architecting Life: Authoring the Future of Species with Dr. Adrian Woolfson
Dr. Adrian Woolfson argues that DNA must be treated as a programmable engineering material, enabling the design of living systems from houses to organs. By decoding DNA's generative grammar, humanity could author genomes and potentially rewrite its own code, ushering...
Muscle Mass Predicts Older Adults' Survival Better than BMI
Muscle mass is a stronger predictor of survival than BMI in older adults Read here: https://www.sciencedirect.com/science/article/abs/pii/S0002934314001387
Novant Health Taps Chief Growth Officer
Novant Health announced that Richard Divers will assume the role of senior vice president and chief growth officer on April 13. Divers will steer the system’s enterprise growth strategy, covering mergers and acquisitions, strategic partnerships, and expansion projects aimed at widening...
Top 15 Specialty Pharmacies of 2025: Report
The Drug Channels report shows the specialty pharmacy market remains tightly concentrated, with PBM‑affiliated chains capturing roughly two‑thirds of dispensing revenue in 2025. Specialty drug spending rose 9.6% to $293.4 billion, while accredited locations topped 1,900, a 3% year‑over‑year increase. Hospital‑owned...
Residents in some Neighborhoods Live 30 Years Longer. Researchers Developed a Model to Close that Gap.
Researchers at Rice University, the University of Louisville and Simmons College introduced the Universal Basic Neighborhood (UBN) model to equalize life expectancy across U.S. communities. By evaluating 35 health‑supporting metrics—environment, housing, social and transportation—the model aims for every neighborhood to...
'It's Just the Beginning' For Pancreatic Cancer's Long-Awaited Breakthrough
Revolution Medicines’ KRAS‑G12D inhibitor daraxonrasib has entered late‑stage trials as a potential first‑in‑class therapy for pancreatic cancer, a disease that still carries a five‑year survival rate below 12%. Early data show tumor shrinkage in roughly a third of heavily pre‑treated...
SMMT Spikes as Akeso OS Data Lands Plenary
Summit Thera. $SMMT Well… that answers that. SMMT shares initially popped (as much as ~15%) on today’s release of ASCO abstract titles with the unexpected news that the much-anticipated OS data from Akeso’s HARMONi-6 will be released in a Plenary slot...
ASCO26 Unveils Pancreatic
#ASCO26 abstract titles were released today: $RVMD RASolute Ph3 study in pancreatic cancer will be presented during the plenary session. Also, Akeso $SMMT ivonescimab HARMONi-6 trial in lung cancer. China-only data.
PBM Proposed Transparency Rule Supported by Public Comment
The U.S. Department of Labor has closed a public comment period on a proposed rule that would require pharmacy‑benefit managers to disclose all direct and indirect compensation to self‑insured employer health‑plan sponsors. The accelerated rule, opened on Jan. 30 and closed...
Military Ends Mandatory Flu Shots, Reversing Centuries‑Old Policy
1/2 The military moving backwards on vaccines (recent announcement making flu vax no longer mandatory) reverses a long history that goes back to Washington and smallpox, and has continued to the (almost) present day - see below from @EvidenceOpen ...
Future Leaders Must Master Supply Chains, Healthcare, AI
Supply chain taught me how systems move. Healthcare taught me what’s at stake. AI is changing what those systems can become. The next era will belong to leaders who understand all three. Excited to speak where that future starts to...
Yelp Partners with Zocdoc to Launch Real-Time Healthcare Appointment Booking
Yelp has teamed up with Zocdoc to embed real‑time medical appointment booking directly into doctor business pages on its iOS app, leveraging Zocdoc’s scheduling engine and the new AI‑driven Yelp Assistant chatbot. The feature displays in‑network availability and lets patients...
BioAge's Inflammation Drug Shows Best‑in‑class Promise
BioAge says early data suggest ‘best-in-class’ potential for inflammation drug https://t.co/D2owlYxCRa by Kristin Jensen $BIOA $LLY $NMRA
Frictionless Access Is Healthcare’s Next Front Door
Mount Sinai is overhauling its patient‑front‑door by integrating CLEAR’s digital identity platform, giving patients and staff an optional, fast‑track check‑in experience. The hospital used focus groups to shape a solution that blends digital convenience with traditional registration for those who...
Hospice Fraud a ‘Terrifying’ Beneficiary Protection Issue
U.S. lawmakers highlighted a surge in hospice and home‑health fraud, with California, Arizona, Nevada, Texas, Georgia and Ohio flagged as hotspots. In Los Angeles County, provider numbers jumped 1,500% since 2010, leading to at least $105 million in Medicare overbilling and...
MiniMed Posts Double-Digit Sales Growth, Widening Net Loss
MiniMed, Medtronic’s diabetes‑tech spinoff, posted FY26 Q3 revenue of $790 million, up 15 % year‑over‑year, but its net loss widened dramatically to $119 million from $10 million a year earlier. Growth was driven by sales of its automated insulin‑delivery system, FDA clearance for the...
South Carolina System Opens Outpatient Pharmacy
McLeod Health in Florence, South Carolina, opened a new 12,000‑square‑foot outpatient pharmacy on April 26, replacing a 2,200‑square‑foot location inside its hospital tower. The expanded site, repurposed from a former emergency‑department space, adds a drive‑through window, curbside pickup, and a...
ECRI Spins Off Supply Tech Company
ECRI has spun off its healthcare spend and recall management unit into a new independent company called Staritas. Staritas will deliver data‑driven supply chain intelligence, leveraging AI and real‑time analytics used by nearly 90% of top U.S. hospitals and providers...
Mount Sinai Launches Women’s Health Podcast Series
Mount Sinai Health System has launched “HERology,” a new podcast series dedicated to comprehensive women’s health. The show is co‑hosted by four Mount Sinai physicians and researchers and features both internal specialists and external experts, including public figures. Episodes will...
Revisiting The Competency-Based Board of Directors
Healthcare boards are re‑examining strict competency‑based composition as new regulatory, technological and economic pressures demand broader strategic insight. Traditional governance models that prioritize narrow expertise in areas like M&A, finance or legal risk becoming siloed and less adaptable. Industry surveys...
Carvykti Shows Promise Before Multiple Myeloma; Two Megarounds; AstraZeneca Wins Twice
Researchers at Dana‑Farber Cancer Institute reported that all 20 high‑risk smoldering multiple myeloma patients treated with Carvykti, Janssen's BCMA‑directed CAR‑T therapy, achieved disease clearance. The single‑infusion regimen produced complete responses without immediate relapse, and patients remained progression‑free at a median...
Fining Hospitals for Medical Misogyny Won’t Help Women – It Will Hurt Them
The UK health secretary Wes Streeting proposes "patient power payments" that would cut NHS hospital budgets if women’s experience scores fall short. The move follows a surge in demand: nearly 250,000 women are now on gynecological waiting lists, a figure...
BioAge Says Early Data Suggest ‘Best-in-Class’ Potential for Inflammation Drug
BioAge Labs released Phase 1 data for the 60‑mg dose of its NLRP3 inhibitor BGE‑102, confirming tolerability and inflammation‑lowering activity similar to the earlier 120‑mg readout. The oral pill crosses the blood‑brain barrier, opening possibilities for cardiovascular, obesity, eye and central‑nervous‑system...
UnitedHealth Tops Quarterly Estimates, Hikes Profit Outlook as Insurer Manages High Medical Costs
UnitedHealth Group reported first‑quarter earnings that beat Wall Street expectations, posting adjusted earnings per share of $7.23 versus the $6.57 consensus and revenue of $111.72 billion, above the $109.57 billion forecast. The insurer lifted its 2026 adjusted EPS outlook to more than...
Amazon One Medical Launches Nationwide GLP-1 Management Program Integrated with Primary Care
Amazon One Medical has launched a nationwide GLP‑1 obesity management program that embeds weight‑loss drugs within a full primary‑care model. The service, linked to Amazon Pharmacy, offers insurance‑backed pricing as low as $25 a month and cash‑pay options starting at...
New Patient Chatbot Tackles AI's Failing Triage Accuracy
Japanese startup Ubie launched Ubie Consult, a free AI‑driven chatbot that guides patients on whether to self‑manage or seek professional care. Built on a large language model trained with peer‑reviewed medical literature and clinical guidelines, the tool flags high‑risk symptoms like...
If 80-Year-Olds Improve Just as Much as 50-Year-Olds After Lumbar Fusion, Are You Overestimating Surgical Risk — or Underestimating What...
A new age‑stratified analysis of 1,100 posterior lumbar decompression and fusion patients shows that patients 80 years and older experience mortality, readmission, revision and pain‑relief outcomes comparable to younger cohorts. All age groups improved similarly on ODI and visual analog pain...
RFK Denies Trump Sidelining, Confirms Team Vetted CDC Nominee
RFK says today at @HouseCommerce hearing that it's not true that he's been sidelined by Trump bc of his vaccine views, and that while he didn't talk to Trump about Erica Schwartz's nomination to CDC, his team vetted and...
Bridging the Gap Between a Chronic Disease Diagnosis and Treatment
Physicians often assume that a chronic disease diagnosis instantly opens the path to treatment, but patients need time to internalize the new identity the diagnosis imposes. Dr. Donald Kushner illustrates this gap through cases where patients hesitated or refused therapy...
Early Myocarditis Onset After Immunotherapy May Predict Treatment-Related Fatality
A new analysis of WHO VigiBase data presented at the AACR 2026 meeting shows that immune checkpoint inhibitor (ICI)‑induced myocarditis occurring within the first month of therapy dramatically increases the risk of death. Patients who develop myocarditis early are 59%...
Bullying and Adverse Social Climate Take Measurable Toll on Mental Health of Gender-Diverse Youth: Study
UCLA Health researchers analyzed data from the large Adolescent Brain Cognitive Development study and found that gender‑diverse adolescents experience higher rates of bullying and psychotic‑like experiences (PLEs) than their peers. Bullying accounted for about 18 % of the mental‑health gap, indicating...
Exposure to Wildfire Smoke May Be Linked to Increased Risk of Developing Several Cancers
A study presented at the AACR 2026 meeting links long‑term exposure to wildfire smoke to markedly higher risks of several cancers. Analyzing 91,460 participants from the PLCO Cancer Screening Trial, researchers found each 1 µg/m³ rise in wildfire‑related PM2.5 increased lung...
Intralesional Nivolumab May Be Effective Against Precancerous Oral Lesions, Phase I Trial Results Indicate
A Phase I trial presented at AACR 2026 showed that injecting low‑dose nivolumab directly into precancerous oral lesions produced an 85% clinical response rate, with lesions shrinking an average of 60% and 41% achieving histologic downgrading. Patients received 10 mg or 20 mg...
CellCarta Eliminates 9-Hours-Per-Week Regulatory Bottleneck with RegASK’s AI-Driven Intelligence Platform
CellCarta, a global contract research organization, partnered with RegASK to overhaul its regulatory intelligence function. By deploying RegASK’s agentic AI platform, the CRO replaced a manual nine‑hour‑per‑week monitoring process with near‑real‑time updates. The new centralized hub automatically captures, validates and...
Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs
Agenus appointed BAP Pharma as its exclusive global partner to manage early‑access programs for the botensilimab‑balstilimab (BOT+BAL) immunotherapy combo. The collaboration will handle France’s government‑reimbursed Autorisation d’Accès Compassionnel (AAC) pathway and paid named‑patient programs in several other markets. Agenus has...
Charles River Highlights Effectiveness of VCGs in Toxicology
Charles River Laboratories published a retrospective analysis of 20 nonclinical toxicology studies that replaced traditional concurrent control groups with virtual control groups (VCGs). The review found 100% concordance in No Observed Adverse Effect Level (NOAEL) determinations and demonstrated up to...
Star Therapeutics Receives FDA Rare Pediatric Disease and Breakthrough Therapy Designations for VGA039 in Von Willebrand Disease Prophylaxis
Star Therapeutics announced that the FDA has granted both rare pediatric disease and Breakthrough Therapy designations to its lead candidate VGA039, a monoclonal antibody aimed at preventing bleeding in von Willebrand disease (VWD). The designations support the ongoing Phase 3 VIVID‑6 study,...
The AgeTech Collaborative™ From AARP and HLTH Launch Landmark Collaboration to Advance the Future of Aging
HLTH Inc. and AARP’s AgeTech Collaborative have announced a landmark partnership to accelerate aging‑technology startups. The collaboration will feature 20 vetted companies at HLTH 2026 in Las Vegas, giving them exposure to investors, health systems, and industry leaders. Leveraging AARP’s longevity expertise...
MRNA Brand Stigmatized by COVID Vaccine Backlash, Says Bhattacharya
That is literally a lie, as Bhattacharya wrote an op-ed trying to explain their move. He essentially was arguing that the "brand" of mRNA is tainted by public backlash to the COVID vaccine. https://t.co/5KXQJtCCxM https://t.co/HDQRvQK0ki
Patient-Surgeon Sex Mismatch Doesn’t Drive Disparities in Cardiac Surgery
A new analysis of 223,065 Medicare cardiac surgery patients found that surgeon‑patient sex mismatch does not affect 30‑day or five‑year mortality and morbidity. Whether a male or female surgeon operated on a male or female patient showed no independent association...
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products
Simulations Plus announced a funded collaboration with CDMO Lonza and the U.S. FDA to create a mechanistic, predictive framework for amorphous solid dispersion (ASD) oral drugs. The partnership will combine Lonza's advanced in‑vitro dissolution testing with Simulations Plus' GastroPlus and...
Judge Postpones OxyContin-Maker Purdue Pharma’s Sentencing to Let Opioid Victims Attend in Person
U.S. District Judge Madeline Cox Arleo postponed Purdue Pharma’s criminal sentencing to allow opioid‑crisis victims to attend the hearing in person. The original sentencing, slated for a videoconference, was moved to the following Tuesday after protesters gathered outside the Newark...
More than 70% of CFOs Report Margins of 2% or Less
A recent LeanTaaS survey of 100 U.S. hospital CFOs reveals that 72% are operating with profit margins of 2% or less, a level comparable to low‑margin retail. The primary pressures stem from declining reimbursement rates, reduced government funding, rising labor...
1 in 5 US Blood Donors Show Sign of Prediabetes or Diabetes, Study Finds
A new analysis by the American Red Cross of more than 920,000 U.S. blood donors found that one in five exhibits hemoglobin A1C levels indicating prediabetes or diabetes. Roughly 80% of those elevated readings fall in the prediabetes range, while...
LogiPharma Europe: Why Packaging Must Evolve For Patients
In a follow‑up interview with Pharmaceutical Commerce, Richard Harrop of Topa Thermal argues that pharmaceutical packaging must transition from a product‑centric to a patient‑centric model. The rise of cell and gene therapies and radiopharmaceuticals demands smaller, intuitive, temperature‑controlled packs that...
Cancer-Like Microglial Mutations May Fuel Alzheimer's Inflammation
Somatic mutations in microglia brain cells (the same mutations as seen in cancer) are enriched in and may drive the neuroinflammation of Alzheimer's disease @CellCellPress https://t.co/PS7pIBFW4H
Combining Cannabis with Opioids Offers No Added Pain Relief for Knee Arthritis Patients, Study Concludes
Researchers conducted a double‑blind, placebo‑controlled trial with 21 knee‑osteoarthritis patients to evaluate whether dronabinol, a synthetic THC, enhances the analgesic effect of hydromorphone. The study found that neither drug alone, nor their combination, produced meaningful acute pain relief during laboratory...